Myomo (NYSEAMERICAN:MYO) Price Target Raised to $11.00 at Craig Hallum

Myomo (NYSEAMERICAN:MYO) had its target price raised by Craig Hallum from $9.00 to $11.00 in a research report issued on Tuesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Craig Hallum’s price target would suggest a potential upside of 84.56% from the stock’s current price.

Several other brokerages also recently commented on MYO. Ascendiant Capital Markets upped their price target on shares of Myomo from $8.50 to $9.00 and gave the company a “buy” rating in a research report on Tuesday, November 12th. HC Wainwright reaffirmed a “buy” rating and issued a $7.50 target price on shares of Myomo in a research report on Wednesday, November 13th.

Myomo Price Performance

NYSEAMERICAN:MYO opened at $5.96 on Tuesday. The firm has a market capitalization of $180.29 million, a P/E ratio of -24.74 and a beta of 1.68. Myomo has a 1-year low of $2.51 and a 1-year high of $7.17.

Institutional Trading of Myomo

Several hedge funds and other institutional investors have recently modified their holdings of MYO. Barclays PLC acquired a new position in Myomo during the third quarter worth $36,000. BNP Paribas Financial Markets acquired a new stake in Myomo in the 4th quarter worth approximately $64,000. Walleye Capital LLC acquired a new position in Myomo during the fourth quarter valued at approximately $66,000. Squarepoint Ops LLC acquired a new position in Myomo during the fourth quarter valued at approximately $74,000. Finally, Schonfeld Strategic Advisors LLC bought a new position in shares of Myomo in the fourth quarter valued at approximately $95,000. 44.99% of the stock is currently owned by hedge funds and other institutional investors.

Myomo Company Profile

Myomo, Inc, a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient’s weak or paralyzed arm to enable and improve functional activities of daily living.